NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
10.65
-0.47 (-4.23%)
Jan 28, 2026, 12:33 PM EST - Market open
NextCure Market Cap
NextCure has a market cap or net worth of $37.33 million as of January 28, 2026. Its market cap has increased by 66.84% in one year.
Market Cap
37.33M
Enterprise Value
15.26M
1-Year Change
66.84%
Ranking
Category
Stock Price
$10.65
Market Cap Chart
Since May 9, 2019, NextCure's market cap has decreased from $436.51M to $37.33M, a decrease of -91.45%. That is a compound annual growth rate of -30.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 38.98M | -21.63% |
| Dec 31, 2025 | 49.74M | 130.37% |
| Dec 31, 2024 | 21.59M | -32.12% |
| Dec 29, 2023 | 31.81M | -18.77% |
| Dec 30, 2022 | 39.16M | -76.37% |
| Dec 31, 2021 | 165.76M | -44.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kezar Life Sciences | 45.55M |
| Telomir Pharmaceuticals | 45.21M |
| Plus Therapeutics | 44.28M |
| INmune Bio | 44.26M |
| Estrella Immunopharma | 44.14M |
| Anebulo Pharmaceuticals | 43.55M |
| Veru Inc. | 42.29M |
| Jasper Therapeutics | 42.26M |